Related Experiment Video

Updated: Jun 6, 2026

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

Arrhythmia models: in vivo, in vitro and in silico

Fadi G Akar1, Colleen E Clancy

  • 1Cardiovascular Institute, Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA. fadi.akar@mssm.edu.

Drug Discovery Today. Disease Models
|November 13, 2010
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
08:33

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Related Experiment Videos

Last Updated: Jun 6, 2026

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices
09:35

Preclinical Cardiac Electrophysiology Assessment by Dual Voltage and Calcium Optical Mapping of Human Organotypic Cardiac Slices

Published on: June 16, 2020

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
08:33

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

Related Concept Videos

Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.

Articles linked to this work by shared authors, journal, and citation graph.

A hERG blocker facilitates K+ channel current by promoting pore opening while blocking.

The Journal of general physiology·2026

Desmoplakin Loss Leads to PKC- and Src-Mediated Contractile Dysfunction in Cardiomyocytes.

Circulation research·2026

Optical digital twins for disease prevention, diagnosis, therapy, and intervention.

Journal of biomedical optics·2026

BoltzOmics: Predicting genetic variant effects on drug binding with Boltz-2.

iScience·2026

Large-scale synthetic data enable digital twins of human excitable cells.

eLife·2026

A hERG Blocker Facilitates K+ Channel Current by Agonizing Pore Opening while Blocking.

bioRxiv : the preprint server for biology·2026

Genome Wide Conditional Mouse Knockout Resources.

Drug discovery today. Disease models·2024

Cardiac tissue engineering using human stem cell-derived cardiomyocytes for disease modeling and drug discovery.

Drug discovery today. Disease models·2021

Epstein-Barr Virus Infection in the Development of Neurological Disorders.

Drug discovery today. Disease models·2021

Applying the 3Rs to non-human primate research: Barriers and solutions.

Drug discovery today. Disease models·2021

In vitro models of HIV-1 infection of the Central Nervous System.

Drug discovery today. Disease models·2021

Chediak-Higashi syndrome: a review of the past, present, and future.

Drug discovery today. Disease models·2021
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us